Cubist Pharmaceuticals, Inc. - SWOT Analysis
Datamonitor's Cubist Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Cubist Pharmaceuticals (Cubist) is a biopharmaceutical company focused on the research, development and commercialization of anti-infective products in the acute care environment. The company markets Cubicin (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides, in the US. Cubist is headquartered in Lexington, Massachusetts and employs about 500 people. The company recorded revenues of $295 million during the financial year (FY) ended December 2007, an increase of 51.3% over 2006. The significant increase in revenues was primarily due to increase in Cubicin sales, which was a result of increased US customer volume and a 6.2% price increase in January 2007. The operating profit of the company was $41 million during FY2007, as compared to an operating profit of $5 million in 2006. The net profit was $48 million in FY2007, as compared to a net loss of $0.4 million in 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
RELATED REPORTS
Datamonitor's E. I. duPont de Nemours & Company - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines ...
Industries : Healthcare
Datamonitor's Cerner Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ...
Industries : Healthcare
Datamonitor's Bayer AG - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Bayer is a ...
Industries : Healthcare
Datamonitor's CVS Caremark Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and stra ...
Industries : Healthcare
Datamonitor's ViroPharma Incorporated - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strat ...
Industries : Healthcare
IntroductionDatamonitor expects the antihypertensives market to reach $37 billion, across the seven major markets, by 2017. The growth will be driven by the uptake of Novartis's Tekturna, as well as increased use of ARBs, and their combinations. However, the expiries of some key patents, particularl ...
Industries : Healthcare
IntroductionIn 2008, the six tumor types covered in this report are forecast to account for over 666,000 new cases of cancer, obviously representing an enormous market potential. However, it is the higher-incidence tumor types that continue to attract drug developers, with lower-incidence cancers po ...
Industries : Healthcare
IntroductionThis analysis examines the historical and forecast performance for Pfizer in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An intera ...
Industries : Healthcare
SynopsisAnalysis and opinion on monthly deal activity, along with the trend for the last six months for merger and acquisition (M&A), private equity, private placement, IPO, and secondary offering deals.IntroductionThis report contains extensive qualitative and quantitative analysis of monthly deal ...
Industries : Healthcare
Adventist Health System Healthcare - Managed Care & Hospitals SWOT Report is a comprehensive report of the company including both quantitative and qualitative research. The report examines the company’s business structure and operations, history and products. The report provides strategic insigh ...
Industries : Healthcare
Related industries
reportlinker.com © Copyright 2009. All rights reserved